Undifferentiated spondyloarthropathy
Conditions
Interventions
Control group:Meloxicam Tablets
Experimental group:Conventional western medicine + Yunpi Jiedu Tongdu granule
Sponsors
Zhejiang Chinese Medicine University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Classification definition in line with undifferentiated spine joint disease; 2.Patients with unified spine joint diseases that meet spleen deficiency and wet poisonous sputum; 3.18 years old to 65 years old; 4 patients were informed and agreed to participate in this study.
Exclusion criteria
Exclusion criteria: 1. Those who have been treated with biological agents within 2 months; 2. Those with severe organ disease or mental illness; 3. Those who are allergic to or have contraindications to the drugs involved in the research protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The rate of transforming to Spondyloarthritis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Ankylosing spondylitis disease activity score;Ankylosing spondylitis BASDAI score;Ankylosing spondylitis BASFI score;Health Survey Short Form;NMR SPARCC score;TCM syndrome score; | — |
Countries
China
Contacts
Public ContactWen Chengping
Zhejiang Chinese Medicine University
Outcome results
None listed